| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2006.11.043 |
| P698 | PubMed publication ID | 17125739 |
| P2093 | author name string | Kei Maruyama | |
| Masashi Asai | |||
| Shoichi Ishiura | |||
| Takaomi C Saido | |||
| Nobuhisa Iwata | |||
| Yoshimi Aizaki | |||
| Ayumu Yoshikawa | |||
| P2860 | cites work | Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract | Q46851793 |
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 498-502 | |
| P577 | publication date | 2006-11-15 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion | |
| P478 | volume | 352 |
| Q35106666 | A systematic review of single chinese herbs for Alzheimer's disease treatment |
| Q38162961 | Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease |
| Q39508787 | An alternative metabolic pathway of amyloid precursor protein C‐terminal fragments via cathepsin B in a human neuroglioma model |
| Q55363040 | Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease |
| Q83287350 | Berberine Inhibits Lipopolysaccharide- and Polyethylene Particle-Induced Mouse Calvarial Osteolysis In Vivo |
| Q90263721 | Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation |
| Q28537637 | Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells |
| Q86633599 | Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats |
| Q40521776 | Berberine protects against light-induced photoreceptor degeneration in the mouse retina |
| Q37914665 | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
| Q48519957 | Bererine induces peripheral lymphocytes immune regulations to realize its neuroprotective effects in the cerebral ischemia/reperfusion mice |
| Q98778967 | Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression |
| Q41363134 | Chemical and Biological Aspects of Extracts from Medicinal Plants with Antidiabetic Effects |
| Q88419158 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential |
| Q59034364 | Comment on “Berberine and Its Emerging Benefits in Psychiatric Conditions Especially Alzheimer′s Disease” |
| Q36247233 | Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study |
| Q38221853 | Comparison of Two Old Phytochemicals versus Two Newly Researched Plant-Derived Compounds: Potential for Brain and Other Relevant Ailments |
| Q41679990 | Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway. |
| Q34094808 | Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells |
| Q46058236 | Efficacy of Berberine, an Antimicrobial Plant Alkaloid, as an Endodontic Irrigant against a Mixed-culture Biofilm in an In Vitro Tooth Model |
| Q93037059 | Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein |
| Q39314523 | Gold nanoparticle based dot-blot immunoassay for sensitively detecting Alzheimer's disease related β-amyloid peptide |
| Q104694703 | In vitro and in silico studies of the larvicidal and anticholinesterase activities of berberine and piperine alkaloids on Rhipicephalus microplus |
| Q40484195 | In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumoniae |
| Q53130900 | Interaction of Herbal Compounds with Biological Targets: A Case Study with Berberine |
| Q45754246 | Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator |
| Q28542840 | Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury |
| Q40230831 | Molecular Modeling on Berberine Derivatives toward BuChE: An Integrated Study with Quantitative Structure-Activity Relationships Models, Molecular Docking, and Molecular Dynamics Simulations |
| Q26750581 | Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview |
| Q37546190 | Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research |
| Q58692870 | Neuroprotective Role of Phytochemicals |
| Q39370839 | Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants |
| Q58133808 | Neuroprotective effects of berberine in neurodegeneration model rats induced by ibotenic acid |
| Q90259404 | Nigella sativa and thymoquinone attenuate oxidative stress and cognitive impairment following cerebral hypoperfusion in rats |
| Q93000399 | Phytochemicals against TNFα-Mediated Neuroinflammatory Diseases |
| Q28263471 | Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review |
| Q86199455 | Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease |
| Q41622472 | Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms |
| Q38668992 | Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors |
| Q92772584 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study |
| Q49773776 | Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and Aging-Related Diseases via Anti-Oxidation and AMPK Activation |
| Q36824291 | Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections |
| Q28067321 | Role of berberine in Alzheimer's disease |
| Q35112532 | Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor |
| Q38262767 | Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus |
| Q37544305 | Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects |
| Q36036555 | The Components ofFlemingia macrophyllaAttenuate Amyloidβ-Protein Accumulation by Regulating Amyloidβ-Protein Metabolic Pathway |
| Q28546885 | Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model |
| Q38370031 | Therapeutic potential of berberine against neurodegenerative diseases |
| Q34093038 | Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: binding aspects and implications for drug design |
Search more.